National Health Investors

NHI · NYSE

$66.35+$1.65 (+2.55%)TodayMarket closed ·
Prev close $64.70

Latest news

  • Press releasePRNewswire

    NHI Announces Third Quarter 2026 Earnings Release and Conference Call Dates

  • Press releasePRNewswire

    NHI Announces $107.7 Million SHOP Investment

  • Press releasePRNewswire

    NHI to Participate in the BofA Securities 2026 Global Real Estate Conference; Updates Pipeline

  • Press releasePRNewswire

    NHI Issues Investor Update

  • News

    National Health Investors Q2 FFO $1.19 Misses $1.26 Estimate, Sales $121.319M Beat $111.677M Estimate

  • Press releasePRNewswire

    NHI Announces Second Quarter 2026 Results

  • Press releasePRNewswire

    NHI Appoints Chris Maingot as Chief Operating Officer

  • Press releasePRNewswire

    NHI Announces Second Quarter 2026 Earnings Release and Conference Call Dates

  • Press releasePRNewswire

    Honeywell Aerospace Set to Join S&P 500 & S&P 100; Others to Join S&P MidCap 400 and S&P SmallCap 600

  • Press releasePRNewswire

    NHI Announces the Second Quarter 2026 Dividend

  • Press releasePRNewswire

    NHI Issues Investor Update

  • News

    National Health Investors Q1 FFO $1.23 Beats $1.22 Estimate, Sales $115.130M Beat $105.353M Estimate

  • Press releasePRNewswire

    NHI Announces $106.9 Million SHOP Investment

  • Press releasePRNewswire

    NHI Announces First Quarter 2026 Results

  • News

    Earnings Scheduled For May 4, 2026

  • Press releasePRNewswire

    NHI Announces CFO Succession Plan; John Spaid to Retire, Todd Siefert Named Successor

  • Press releasePRNewswire

    Blueprint acts as transaction advisor to National Health Investors, Inc. (NYSE: NHI) in its planned $560 million disposition of a 35-property healthcare portfolio to National HealthCare Corporation (NYSE American: NHC).

  • Press releaseACCESS Newswire

    NHI Announces Sale of NHC Portfolio for $560 Million

  • Press releaseACCESS Newswire

    NHI Announces First Quarter 2026 Earnings Release and Conference Call Dates

  • News

    Earnings Breakdown: National Health Investors Q4

  • Press releaseACCESS Newswire

    NHI Issues Investor Update

  • Press releaseACCESS Newswire

    NHI Announces Fourth Quarter 2025 Results

  • Press releaseACCESS Newswire

    NHI Announces $89.2 Million in Investments and Updates Pipeline

  • Press releaseACCESS Newswire

    NHI Announces Fourth Quarter 2025 Dividend

  • Press releaseACCESS Newswire

    NHI Issues Investor Update

  • Press releaseACCESS Newswire

    NHI Announces Third Quarter 2025 Results

  • News

    Earnings Scheduled For November 6, 2025

  • Press releaseACCESS Newswire

    NHI Issues Investor Update

  • Press releaseACCESS Newswire

    NHI Announces Second Quarter 2025 Results

  • Press releaseACCESS Newswire

    NHI Announces Increase for the Third Quarter 2025 Dividend

  • Press releaseBusiness Wire

    Land & Buildings Details Why National Healthcare Corp. Could Lose Big as Lease Negotiation with National Health Investors Progresses

  • Press releaseACCESS Newswire

    NHI Issues Investor Update

  • Press releaseBusiness Wire

    Land & Buildings Comments on Preliminary Results of National Health Investors Annual Meeting

  • Press releaseACCESS Newswire

    NHI Stockholders Elect All Four of NHI's Director Nominees at the 2025 Annual Meeting

  • Press releaseBusiness Wire

    Leading Independent Proxy Advisory Firm ISS Recommends National Health Investors Stockholders Vote FOR Both of Land & Buildings' Director Nominees

  • Press releaseBusiness Wire

    Independent Proxy Advisory Firm Glass Lewis Recommends National Health Investors Stockholders Vote FOR Both of Land & Buildings' Director Nominees

  • Press releaseACCESS Newswire

    NHI Issues Investor Update

  • Press releaseBusiness Wire

    Land & Buildings Sends Letter to National Health Investors Stockholders and Files Definitive Proxy Materials Detailing Urgent Need for Boardroom Change

  • NewsAvi Kapoor

    Top 3 Real Estate Stocks Which Could Rescue Your Portfolio In Q4

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.